Slowly Digestible Carbohydrates for GLP-1 Secretion
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 19
- 试验地点
- 1
研究概览
简要总结
The goal of this clinical trail is to learn if the hormone, glucagon-like peptide-1 (GLP-1), is stimulated by slowly digestible carbohydrates (SDCs) in healthy adults. In the current study, researchers will observe the amount of SDC that results in clinically meaningful levels of GLP-1, shown by an increase in feelings of fullness and a decrease in hunger, and how long an elevated level of GLP-1 lasts after starch consumption. Researchers aim to address two questions: What amount of SDC maximizes GLP-1-mediated satiety, and does the impact to satiety continue in a second meal? The overall goal is to maximize ileal-digesting SDC's potential use as a food-based agent for weight loss.
Researchers will compare 20, 40, and 60 g of raw corn starch compared to a maltodextrin control on total plasma GLP-1 concentrations, insulin, and blood glucose at baseline and 15, 30, 60, 90, 120, and 180 minutes post-consumption of SDC. Researchers will also measure satiety at baseline, 60, 120, 180 minutes and after a second meal.
There will be a total of 4 study visits with a least a 7-day break between visits. At each study visit, participants will:
- Consume a randomized test beverage (SDC or maltodextrin)
- Receive a blood draw at 7 timepoints over 3 hrs
- Take a satiety questionnaire 5 times over 3 hrs
- Consume a standardized lunch 3 hrs after the test beverage consumption
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy population
- •BMI between 18.5 and 24.9 kg/m2
- •Adults 18 - 45 years old
- •Men or women
- •Able to read/speak English
- •Fasting blood glucose levels ≤100 mg/dL
- •HbA1c ≤ 5.7%
排除标准
- •Participants with 18 > Years of Age > 45 will be excluded.
- •Subjects with 18.5 kg/m² > BMI > 24.9 kg/m² will be excluded.
- •Diabetic individuals will be excluded.
- •Individuals with history of gastrointestinal disease will be excluded from the study.
- •Pregnant or nursing women will also be excluded.
- •Individuals taking GLP-1 medications, or on weight-loss diets or restrictive eating patterns.
- •Individuals suffering from dairy or gluten intolerance or allergies will be excluded.
研究者
Bruce R. Hamaker
Principle Investigator
Purdue University
